• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

Merck covid 19 pill
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
Pfizer logo pill
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By Matthew Perrone and The Associated PressDecember 22, 2021
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
Health
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
By Lauran Neergaard, Matthew Perrone and The Associated PressNovember 19, 2021
Pfizer CEO Albert Bourla
Health
Pfizer seeks emergency FDA authorization for COVID-19 pill
By Matthew Perrone and The Associated PressNovember 16, 2021
FDA authorizes COVID vaccine for kids ages 5 to 11
Health
FDA authorizes COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 29, 2021
Vaccines for kids
Health
FDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 26, 2021
Moderna vaccine
Health
FDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 20, 2021
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
Health
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 14, 2021
FDA will not make a decision on Merck’s COVID antiviral pill until December
Health
FDA will not make a decision on Merck’s COVID antiviral pill until December
By Matthew Perrone and The Associated PressOctober 14, 2021
FDA debates timeline for administering Johnson & Johnson booster shots
Health
FDA debates timeline for administering Johnson & Johnson booster shots
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 13, 2021
FDA panel will advise on Johnson & Johnson booster shots this week
Health
FDA panel will advise on Johnson & Johnson booster shots this week
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By Matthew Perrone and The Associated PressOctober 1, 2021
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
Health
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
By Matthew Perrone, Lauran Neergaard, Mike Stobbe and The Associated PressSeptember 22, 2021
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
Health
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
By Matthew Perrone, Lauran Neergaard and The Associated PressSeptember 17, 2021
1...
  • 4
  • 5
  • 6
  • 7
  • 8
8
Most Popular
Arts & Entertainment
Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine commentsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 18, 2026
C-Suite
Meet Warren Buffett's son Howard, a former sheriff, war photographer, and now, Berkshire's new chairmanplaceholder alt text
By Catherina GioinoSeptember 18, 2026
Success
Billionaire TikTok founder is now the richest person in all of Asia, with a $105 billion net worth—he's gained $92 billion since 2019 thanks to AIplaceholder alt text
By Emma BurleighSeptember 17, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.